Triple

T11074689
Position Surface form Disambiguated ID Type / Status
Subject Docetaxel E261833 entity
Predicate instanceOf P0 FINISHED
Object taxane C29145 CONCEPT FINISHED

How this triple was built (1 step)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

CD Concept disambiguation gpt-5-mini-2025-08-07
Target class: taxane
Context triple: [Docetaxel, instanceOf, taxane]
  • A. fluoropyrimidine
    Fluoropyrimidines are a class of antimetabolite chemotherapy drugs structurally related to pyrimidine that inhibit DNA and RNA synthesis, commonly used in the treatment of various solid tumors.
  • B. antimetabolite
    An antimetabolite is a drug that mimics natural cellular metabolites to interfere with DNA or RNA synthesis, thereby inhibiting cell growth and division, commonly used in cancer and autoimmune disease treatment.
  • C. antineoplastic immunomodulating agent
    An antineoplastic immunomodulating agent is a drug that treats cancer by modifying or enhancing the body’s immune response to recognize and destroy malignant cells.
  • D. angiogenesis inhibitor
    An angiogenesis inhibitor is an agent that blocks the formation of new blood vessels, typically to restrict blood supply to tumors or abnormal tissues.
  • E. CDK4/6 inhibitor
    A CDK4/6 inhibitor is a targeted anticancer drug that blocks cyclin-dependent kinases 4 and 6 to halt cell cycle progression from G1 to S phase, thereby inhibiting tumor cell proliferation.
  • F. None of above. chosen

Provenance (1 batch)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aa9983c08190b0ef61603b69feac completed April 8, 2026, 7:20 p.m.
Created at: April 8, 2026, 9:26 p.m.